New drug could restore 80 percent of hair loss in alopecia patients
Pfizer’s new hair loss drug, LITFULO (Ritlecitinib) curated for those with severe alopecia areata is the first and only treatment approved by the FDA for adolescents above the age of 12.
| Jun 27, 2023 11:16 AM EST
Created: Jun 27, 2023 11:16 AM EST
Individuals suffering from alopecia areata can be now treated with an FDA-approved oral drug